Ideal Patient to Receive Alimata Plus Keytruda: KEYNOTE-189

Ideal Patient to Receive Alimata Plus Keytruda: KEYNOTE-189

User Photo
obr

1 year
117 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Ravi Salgia, MD, Professor and Chair, Department of Medical Oncology and Therapeutics Research, Associate Director for Clinical Sciences, Arthur and Rosalie Kaplan Endowed Chair in Medical Oncology, City of Hope explains the ideal patient to receive Alimta plus Keytrude based on data and results from KEYNOTE-189.
Up Next Autoplay